Bavarian Nordic’s Mpox Vaccine Receives Recommendation from US CDC Advisory Committee for Routine Use in Adults at Risk

Bavarian Nordic announced that the US Centers for Disease Control (CDC) and Prevention’s Advisory Committee on Immunization Practices has voted in favor of recommending the routine use of JYNNEOS®, the company’s FDA-approved mpox vaccine, in adults at risk of mpox infection.